Citigroup Inc Legend Biotech Corp Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Citigroup Inc holds 43,480 shares of LEGN stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,480

Previous 39,704 9.51%

Holding current value

$2.14 Million

Previous $2.23 Million 13.52%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$39.5 - $57.22 $149,152 - $216,062	3,776 Added 9.51%	43,480 $1.93 Million
Q1 2024 May 10, 2024	SELL	$55.06 - $69.99 $1.7 Million - $2.16 Million	-30,795 Reduced 43.68%	39,704 $2.23 Million
Q4 2023 Feb 09, 2024	SELL	$57.25 - $69.74 $509,238 - $620,337	-8,895 Reduced 11.2%	70,499 $4.24 Million
Q3 2023 Nov 09, 2023	BUY	$63.16 - $76.5 $279,609 - $338,665	4,427 Added 5.91%	79,394 $5.33 Million
Q2 2023 Aug 10, 2023	SELL	$46.28 - $75.01 $375,006 - $607,806	-8,103 Reduced 9.75%	74,967 $5.17 Million
Q1 2023 May 11, 2023	BUY	$43.42 - $57.37 $315,446 - $416,793	7,265 Added 9.58%	83,070 $4.01 Million
Q4 2022 Feb 09, 2023	BUY	$38.8 - $55.46 $213,050 - $304,530	5,491 Added 7.81%	75,805 $3.78 Million
Q3 2022 Nov 10, 2022	SELL	$38.15 - $57.1 $1.68 Million - $2.52 Million	-44,082 Reduced 38.53%	70,314 $2.87 Million
Q2 2022 Aug 10, 2022	BUY	$33.54 - $55.0 $1.78 Million - $2.92 Million	53,094 Added 86.61%	114,396 $6.29 Million
Q1 2022 May 12, 2022	BUY	$31.02 - $48.18 $347,051 - $539,037	11,188 Added 22.33%	61,302 $2.23 Million
Q4 2021 Feb 10, 2022	BUY	$41.14 - $56.98 $1.42 Million - $1.97 Million	34,543 Added 221.84%	50,114 $2.34 Million
Q3 2021 Nov 10, 2021	BUY	$35.31 - $50.56 $549,812 - $787,269	15,571 New	15,571 $788,000

Others Institutions Holding LEGN

# of Institutions

198

Shares Held

74.2M

Call Options Held

374K

Put Options Held

387K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.25B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account